Integrating Functional Marrow Reserve and Molecular Risk Improves Prediction of Post-Transplant Outcomes in MDS

Luis E. Aguirre(Harvard University), Rami S. Komrokji(Moffitt Cancer Center), Roman M. Shapiro(Boston University), Marlise R. Luskin(Dana-Farber Cancer Institute), David A. Sallman(Moffitt Cancer Center), Jeffrey E. Lancet(Cornell University), Eric Padron(Moffitt Cancer Center), Haesook T. Kim(Dana-Farber Cancer Institute), Andrew Kuykendall(Moffitt Cancer Center), Zhuoer Xie(Mayo Clinic), Shai Shimony(Twitter (United States)), Evan C. Chen(Dana-Farber Cancer Institute), Stacey M. Frumm(Dana-Farber Cancer Institute), Amar H. Kelkar(Harvard University), Onyee Chan(Moffitt Cancer Center), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Vincent Ho(Dana-Farber Cancer Institute), Kendra Sweet(Moffitt Cancer Center), Maximilian Stahl(Yale Cancer Center), Martha Wadleigh(Dana-Farber Cancer Institute), Robert J. Soiffer(Dana-Farber Cancer Institute), Joseph H. Antin(Dana-Farber Cancer Institute), Corey S. Cutler(Dana-Farber Cancer Institute), Mahasweta Gooptu(Dana-Farber Cancer Institute), John Koreth(Dana-Farber Cancer Institute), Rizwan Romee(Dana-Farber Cancer Institute), Hany Elmariah(Stanford Blood Center), Richard M. Stone(Dana-Farber Cancer Institute), Sarah Nikiforow(Dana-Farber Cancer Institute), Jacqueline S. Garcia(Dana-Farber Cancer Institute), Najla Al Ali(Moffitt Cancer Center), Eric S. Winer(Providence College)
Blood Neoplasia
July 1, 2026
Cited by 0


Related Papers